Flemming Bendtsen

Flemming Bendtsen's AcademicInfluence.com Rankings

Flemming Bendtsen

Philosophy

#9075

World Rank

#12577

Historical Rank

Logic

#6071

World Rank

#7552

Historical Rank

philosophy Degrees

Download Badge

Philosophy

Flemming Bendtsen's Degrees

PhD Biomedical Sciences University of Copenhagen
Doctorate Medicine University of Copenhagen

Why Is Flemming Bendtsen Influential?

(Suggest an Edit or Addition)

(See a Problem?)

Flemming Bendtsen's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

Liver Fibrosis, but No Other Histologic Features, Is Associated With Long-term Outcomes of Patients With Nonalcoholic Fatty Liver Disease. (2015) (1958)
Increasing Incidences of Inflammatory Bowel Disease and Decreasing Surgery Rates in Copenhagen City and County, 2003–2005: A Population-Based Study from the Danish Crohn Colitis Database (2006) (543)
Long term prognosis of fatty liver: risk of chronic liver disease and death (2004) (492)
Recombinant factor VIIa for upper gastrointestinal bleeding in patients with cirrhosis: a randomized, double-blind trial. (2004) (404)
Recombinant factor VIIa for variceal bleeding in patients with advanced cirrhosis: A randomized, controlled trial (2008) (301)
Low cardiac output predicts development of hepatorenal syndrome and survival in patients with cirrhosis and ascites (2009) (297)
Serum YKL-40 is increased in patients with hepatic fibrosis. (2000) (261)
Increased circulating pro-brain natriuretic peptide (proBNP) and brain natriuretic peptide (BNP) in patients with cirrhosis: relation to cardiovascular dysfunction and severity of disease (2003) (219)
Reduced central blood volume in cirrhosis. (1989) (197)
Cirrhotic cardiomyopathy: pathogenesis and clinical relevance (2014) (193)
Effect of omeprazole and cimetidine on duodenal ulcer. A double-blind comparative trial. (1985) (186)
Final results of a long-term, clinical follow-up in fatty liver patients (2009) (184)
Treatment with non-selective beta blockers is associated with reduced severity of systemic inflammation and improved survival of patients with acute-on-chronic liver failure. (2016) (182)
Intraluminal pH in the stomach, duodenum, and proximal jejunum in normal subjects and patients with exocrine pancreatic insufficiency. (1986) (171)
Mortality, cancer, and comorbidities associated with chronic pancreatitis: a Danish nationwide matched-cohort study. (2014) (161)
Disease Course and Surgery Rates in Inflammatory Bowel Disease: A Population-Based, 7-Year Follow-Up Study in the Era of Immunomodulating Therapy (2014) (159)
The PREDICT study uncovers three clinical courses in acutely decompensated cirrhosis with distinct pathophysiology (120/120). (2020) (146)
Infliximab for inflammatory bowel disease in Denmark 1999-2005: clinical outcome and follow-up evaluation of malignancy and mortality. (2008) (142)
The association between the gut microbiota and the inflammatory bowel disease activity: a systematic review and meta-analysis (2016) (138)
Central and systemic haemodynamic effects of terlipressin in portal hypertensive patients. (2000) (128)
Acute non-selective beta-adrenergic blockade reduces prolonged frequency-adjusted Q-T interval (QTc) in patients with cirrhosis. (2004) (124)
Effect of volume expansion on systemic hemodynamics and central and arterial blood volume in cirrhosis. (1995) (123)
Terlipressin improves renal function in patients with cirrhosis and ascites without hepatorenal syndrome (2007) (119)
Plasma YKL-40: a new potential marker of fibrosis in patients with alcoholic cirrhosis? (1997) (117)
Progression From Acute to Chronic Pancreatitis: Prognostic Factors, Mortality, and Natural Course (2011) (112)
Lactate metabolism in chronic liver disease (2013) (111)
Dyssynchronous electrical and mechanical systole in patients with cirrhosis. (2002) (109)
Increased circulating leptin in alcoholic cirrhosis: Relation to release and disposal (1999) (105)
The pathophysiology of arterial vasodilatation and hyperdynamic circulation in cirrhosis (2018) (104)
Agreement among multiple observers on endoscopic diagnosis of esophageal varices before bleeding (1990) (101)
Determinants of the hyperdynamic circulation and central hypovolaemia in cirrhosis (2011) (95)
New insights into cirrhotic cardiomyopathy. (2013) (95)
eHealth: individualisation of infliximab treatment and disease course via a self‐managed web‐based solution in Crohn's disease (2012) (93)
379 Characteristics and Long-Term Prognosis of Lean Patients With Nonalcoholic Fatty Liver Disease (2014) (93)
Increased circulating calcitonin gene-related peptide (CGRP) in cirrhosis. (1991) (92)
Metabolic and inflammatory faecal markers in collagenous colitis (2007) (91)
BNP and N‐terminal proBNP are both extracted in the normal kidney (2006) (90)
Prognostic variables in patients with cirrhosis and oesophageal varices without prior bleeding. (1994) (88)
Blood volume distribution in patients with cirrhosis: aspects of the dual-head gamma-camera technique. (2001) (76)
Reduced baroreflex sensitivity in alcoholic cirrhosis: relations to hemodynamics and humoral systems. (2007) (72)
The Effect of Anti-Tumor Necrosis Factor Alpha Agents on Postoperative Anastomotic Complications in Crohn’s Disease: a Systematic Review (2013) (70)
Estimated central blood volume in cirrhosis: Relationship to sympathetic nervous activity, β‐adrenergic blockade and atrial natriuretic factor (1992) (70)
Plasma volume expansion by albumin in cirrhosis. Relation to blood volume distribution, arterial compliance and severity of disease. (2003) (70)
Cardiac and proinflammatory markers predict prognosis in cirrhosis (2014) (69)
Infliximab and complications after colectomy in patients with ulcerative colitis. (2012) (67)
Effects of a single terlipressin administration on cardiac function and perfusion in cirrhosis (2010) (66)
Effect of propranolol on survival in patients with decompensated cirrhosis: a nationwide study based Danish patient registers (2016) (65)
Extrahepatic complications to cirrhosis and portal hypertension: haemodynamic and homeostatic aspects. (2014) (65)
Pharmacological approach to acute pancreatitis. (2008) (65)
Arterial compliance in patients with cirrhosis: stroke volume-pulse pressure ratio as simplified index. (2001) (64)
Plasma cystatin C is a predictor of renal dysfunction, acute‐on‐chronic liver failure, and mortality in patients with acutely decompensated liver cirrhosis (2017) (64)
Increased abundance of proteobacteria in aggressive Crohn’s disease seven years after diagnosis (2019) (63)
Hospitalisation, surgical and medical recurrence rates in inflammatory bowel disease 2003-2011—a Danish population-based cohort study. (2014) (62)
Increased urinary excretion of aquaporin 2 in patients with liver cirrhosis (2003) (60)
Prolonged Q-T(c) interval in mild portal hypertensive cirrhosis. (2005) (59)
Effect of acetylcysteine on prothrombin index in paracetamol poisoning without hepatocellular injury (2002) (59)
Rifaximin has no effect on hemodynamics in decompensated cirrhosis: A randomized, double‐blind, placebo‐controlled trial (2017) (58)
Dynamics of albumin in plasma and ascitic fluid in patients with cirrhosis. (2001) (57)
Central and noncentral blood volumes in cirrhosis: relationship to anthropometrics and gender. (2003) (57)
Danish patients with chronic pancreatitis have a four-fold higher mortality rate than the Danish population. (2010) (55)
Effects of endogenous GLP-1 and GIP on glucose tolerance after Roux-en-Y gastric bypass surgery. (2016) (54)
Efficacy and safety of terlipressin in cirrhotic patients with variceal bleeding or hepatorenal syndrome (2008) (54)
The risk of fractures among patients with cirrhosis or chronic pancreatitis. (2014) (53)
The cardiorenal link in advanced cirrhosis. (2012) (53)
Circulating atrial natriuretic peptide (ANP) and central blood volume (CBV) in cirrhosis. (2008) (53)
Splanchnic and systemic hemodynamic derangement in decompensated cirrhosis. (2001) (52)
Diurnal variation and dispersion in QT interval in cirrhosis: relation to haemodynamic changes. (2007) (51)
Effects of terlipressin on the aquaretic system: evidence of antidiuretic effects. (2008) (51)
Effect of omeprazole and cimetidine on prepyloric gastric ulcer: double blind comparative trial. (1988) (50)
Vasoactive substances in the circulatory dysfunction of cirrhosis (2001) (50)
Rifaximin has minor effects on bacterial composition, inflammation, and bacterial translocation in cirrhosis: A randomized trial (2018) (49)
Increased arterial compliance in decompensated cirrhosis. (1999) (48)
Effect of recombinant Factor VIIa on outcome of acute variceal bleeding: an individual patient based meta-analysis of two controlled trials. (2014) (47)
Propranolol and haemodynamic response in cirrhosis. (1991) (47)
Cardiac dysfunction in cirrhosis – does adrenal function play a role? A hypothesis (2012) (47)
Kidney injury in cirrhosis: pathophysiological and therapeutic aspects of hepatorenal syndromes (2014) (46)
Plasma cystatin C as a marker of renal function in patients with liver cirrhosis (2002) (45)
Pathogenetic background for treatment of ascites and hepatorenal syndrome (2008) (45)
Carvedilol or propranolol in portal hypertension? A randomized comparison (2012) (44)
Effect of intravenous N-acetylcysteine infusion on haemostatic parameters in healthy subjects (2005) (44)
Treatment of acute ulcerative colitis with infliximab, a retrospective study from three Danish hospitals. (2011) (44)
Differential inflammasome activation predisposes to acute-on-chronic liver failure in human and experimental cirrhosis with and without previous decompensation (2020) (43)
High-sensitivity C-reactive protein levels predict survival and are related to haemodynamics in alcoholic cirrhosis (2012) (42)
Review article: volume expansion in patients with cirrhosis (2002) (42)
Changes in Disease Behaviour and Location in Patients With Crohn’s Disease After Seven Years of Follow-Up: A Danish Population-based Inception Cohort (2018) (40)
Oesophageal pressure–cross‐sectional area distributions and secondary peristalsis in relation to subclassification of systemic sclerosis (2001) (40)
Carbohydrate deficient transferrin (CDT) in alcoholic cirrhosis: a kinetic study. (1997) (39)
Cirrhotic Multiorgan Syndrome (2015) (39)
Effect of terlipressin on blood volume distribution in patients with cirrhosis (2004) (39)
Ascites: Pathogenesis and therapeutic principles (2009) (39)
Arterial hypertension in cirrhosis: arterial compliance, volume distribution, and central haemodynamics (2006) (39)
Carvedilol versus traditional, non-selective beta-blockers for adults with cirrhosis and gastroesophageal varices. (2018) (38)
Bile acids and cardiovascular function in cirrhosis (2017) (38)
Effect of oral propranolol on circulating catecholamines in cirrhosis: relationship to severity of liver disease and splanchnic haemodynamics. (1990) (38)
Effect of antiviral therapy on markers of fibrogenesis in patients with chronic hepatitis C. (2003) (37)
Pro-C5, a marker of true type V collagen formation and fibrillation, correlates with portal hypertension in patients with alcoholic cirrhosis (2015) (37)
Cardiodynamic state is associated with systemic inflammation and fatal acute‐on‐chronic liver failure (2020) (37)
Management of cirrhotic ascites (2015) (37)
Reduced risk of decompensation and death associated with use of statins in patients with alcoholic cirrhosis. A nationwide case‐cohort study (2017) (36)
Pulmonary dysfunction and hepatopulmonary syndrome in cirrhosis and portal hypertension (2009) (36)
Acute decompensation boosts hepatic collagen type III deposition and deteriorates experimental and human cirrhosis (2018) (36)
Effect on hemodynamics of a liquid meal alone and in combination with propranolol in cirrhosis. (1992) (35)
Coronavirus disease 2019, immune-mediated inflammatory diseases and immunosuppressive therapies – A Danish population-based cohort study (2021) (35)
Beta-blockers in cirrhosis and refractory ascites: a retrospective cohort study and review of the literature (2015) (33)
Proximal Disease Extension in Patients With Limited Ulcerative Colitis: A Danish Population-based Inception Cohort (2017) (33)
Effects of tilting on central hemodynamics and homeostatic mechanisms in cirrhosis (2004) (33)
Determinants of the renin-angiotensin-aldosterone system in cirrhosis with special emphasis on the central blood volume (2006) (32)
Relation of calcitonin gene-related peptide to systemic vasodilatation and central hypovolaemia in cirrhosis. (1996) (32)
Efficacy of activated recombinant factor VII (rFVIIa; NovoSeven®) in cirrhotic patients with upper gastrointestinal bleeding: a randomised placebo-controlled double-blind multicenter trial (2003) (31)
Transjugular intrahepatic portosystemic shunt: impact on systemic hemodynamics and renal and cardiac function in patients with cirrhosis. (2018) (31)
Elevated circulating leptin levels in arterial hypertension: relationship to arteriovenous overflow and extraction of leptin. (2000) (31)
The recent reduction in mortality from bleeding oesophageal varices is primarily observed from Days 1 to 5 (2010) (31)
Effects of a long‐acting formulation of octreotide on renal function and renal sodium handling in cirrhotic patients with portal hypertension: A randomized, double‐blind, controlled trial (2001) (31)
Cardiac and renal effects of a transjugular intrahepatic portosystemic shunt in cirrhosis (2013) (30)
PRO-C3-Levels in Patients with HIV/HCV-Co-Infection Reflect Fibrosis Stage and Degree of Portal Hypertension (2014) (30)
A 10-Year Follow-up Study of the Natural History of Perianal Crohn's Disease in a Danish Population-Based Inception Cohort. (2019) (30)
Genetic and environmental factors as predictors of disease severity and extent at time of diagnosis in an inception cohort of inflammatory bowel disease, Copenhagen County and City 2003-2005. (2008) (29)
Duodenal bulb acidity in patients with duodenal ulcer. (1987) (29)
The pharmacokinetics of octreotide in cirrhosis and in healthy man. (1997) (29)
Pathophysiological basis of pharmacotherapy in the hepatorenal syndrome (2005) (28)
Direct and Indirect Costs of Inflammatory Bowel Disease: Ten Years of Follow Up in a Danish Population-Based Inception Cohort. (2019) (28)
New vasoactive peptides in cirrhosis: organ extraction and relation to the vasodilatory state (2014) (27)
Effect of oral propranolol administration on azygos, renal and hepatic uptake and output of catecholamines in cirrhosis (1991) (27)
Histological characteristics and prognosis in patients with fatty liver (2005) (27)
Diastolic and autonomic dysfunction in early cirrhosis: a dobutamine stress study (2014) (26)
Pathophysiological aspects of pulmonary complications of cirrhosis (2007) (26)
Effect of oral propranolol on splanchnic oxygen uptake and haemodynamics in patients with cirrhosis. (1987) (26)
Assessment of response to beta-blockers by expression of βArr2 and RhoA/ROCK2 in antrum mucosa in cirrhotic patients. (2016) (25)
Splanchnic and renal extraction of circulating type III procollagen aminoterminal propeptide in patients with normal liver function and in patients with alcoholic cirrhosis (1990) (25)
Diagnostic performance of Baveno IV criteria in cirrhotic patients with upper gastrointestinal bleeding: analysis of the F7 liver-1288 study population. (2010) (25)
An update on cirrhotic cardiomyopathy (2019) (25)
[785] RECOMBINANT FACTOR VIIA (RFVIIA) FOR ACTIVE VARICEAL BLEEDING IN PATIENTS WITH ADVANCED CIRRHOSIS: A MULTI-CENTRE RANDOMIZED DOUBLE-BLIND PLACEBO-CONTROLLED TRIAL (2007) (25)
Q‐T interval (QTC) in patients with cirrhosis: relation to vasoactive peptides and heart rate (2007) (25)
Indocyanine green retention test (ICG-r15) as a noninvasive predictor of portal hypertension in patients with different severity of cirrhosis (2016) (25)
TIMP-1 in patients with cirrhosis: relation to liver dysfunction, portal hypertension, and hemodynamic changes (2014) (24)
Indications for portal pressure measurement in chronic liver disease (2012) (23)
Myocardial extracellular volume quantified by magnetic resonance is increased in cirrhosis and related to poor outcome (2018) (23)
Long-term effects of oral propranolol on splanchnic and systemic haemodynamics in patients with cirrhosis and oesophageal varices. (1991) (23)
Effects of transjugular intrahepatic portosystemic shunt (TIPS) on blood volume distribution in patients with cirrhosis. (2017) (22)
Splanchnic haemodynamics after intravenous terlipressin in anaesthetised healthy pigs. (1999) (22)
Betablockers induce cardiac chronotropic incompetence. (2012) (22)
Combined antiretroviral therapy attenuates hepatic extracellular matrix remodeling in HIV patients assessed by novel protein fingerprint markers (2014) (22)
Complications of cirrhosis. A 50 years flashback (2015) (21)
Hyponatraemia during terlipressin therapy (2010) (21)
Association of markers of bacterial translocation with immune activation in decompensated cirrhosis (2014) (20)
No difference in portal and hepatic venous bacterial DNA in patients with cirrhosis undergoing transjugular intrahepatic portosystemic shunt insertion (2013) (19)
A phylogenetic analysis elucidating a case of patient-to-patient transmission of hepatitis C virus during surgery. (2000) (19)
Cardiac sympathetic imaging with mIBG in cirrhosis and portal hypertension: relation to autonomic and cardiac function. (2012) (19)
Indocyanine green retention test in cirrhosis and portal hypertension: Accuracy and relation to severity of disease (2018) (19)
Effects of carvedilol and propranolol on circulatory regulation and oxygenation in cirrhosis: a randomised study. (2014) (19)
Effects of Roux-en-Y Gastric Bypass and Sleeve Gastrectomy on Non-Alcoholic Fatty Liver Disease: A 12-Month Follow-Up Study with Paired Liver Biopsies (2021) (19)
Pancreatic insufficiency. Duodenal and jejunal pH, bile acid activity, and micellar lipid solubilization. (1990) (19)
Anti-NKG2D mAb: A New Treatment for Crohn’s Disease? (2017) (18)
Fecal microbiota transplantation in hepatic encephalopathy: a systematic review (2021) (18)
Collagen type IV remodelling gender‐specifically predicts mortality in decompensated cirrhosis (2019) (18)
Cardiac output determined by echocardiography in patients with cirrhosis: comparison with the indicator dilution technique (2003) (18)
Factors associated with long-term mortality in acute pancreatitis (2011) (18)
[Pediatric colonoscopy]. (1998) (18)
Hepatic venous oxygen content in alcoholic cirrhosis and non-cirrhotic alcoholic liver disease. (2008) (17)
Nonalcoholic Fatty Liver Disease Impairs the Liver–Alpha Cell Axis Independent of Hepatic Inflammation and Fibrosis (2020) (17)
Acid–base disturbance in patients with cirrhosis: relation to hemodynamic dysfunction (2015) (17)
Endoscopic Doppler ultrasound for measurement of azygos blood flow. Validation against thermodilution and assessment of pharmacological effects of terlipressin in portal hypertension. (2001) (17)
Validation and Optimization of an Ex Vivo Assay of Intestinal Mucosal Biopsies in Crohn’s Disease: Reflects Inflammation and Drug Effects (2016) (17)
Low Risk of Unemployment, Sick Leave, and Work Disability Among Patients with Inflammatory Bowel Disease: A 7-year Follow-up Study of a Danish Inception Cohort (2015) (17)
The aetiology of acute and chronic pancreatitis over time in a hospital in Copenhagen. (2010) (17)
Cardiac Function in Patients with Early Cirrhosis during Maximal Beta-Adrenergic Drive: A Dobutamine Stress Study (2014) (16)
Increased circulating calcitonin in cirrhosis. Relation to severity of disease and calcitonin gene-related peptide. (2000) (16)
The relationship between the use of statins and mortality, severity, and pancreatic cancer in Danish patients with chronic pancreatitis (2018) (16)
Hepatorenal syndrome in cirrhosis: diagnostic, pathophysiological, and therapeutic aspects (2016) (15)
The role of the glutathione S-transferase genes GSTT1, GSTM1, and GSTP1 in acetaminophen-poisoned patients (2012) (15)
Profermin is Efficacious in Patients with Active Ulcerative Colitis—A Randomized Controlled Trial (2013) (15)
The insulin-like growth factor binding protein 3 ternary complex is reduced in cirrhosis. (2001) (15)
Does cardiac dysfunction explain deleterious effects of beta‐blockers in cirrhosis and refractory ascites? (2011) (15)
Progressive alcohol‐related liver fibrosis is characterised by imbalanced collagen formation and degradation (2021) (15)
Safety and efficacy of Profermin® to induce remission in ulcerative colitis. (2012) (15)
Serum levels of short‐chain fatty acids in cirrhosis and hepatic coma (1991) (15)
Cardiac dysfunction in cirrhosis: a 2-year longitudinal follow-up study using advanced cardiac imaging. (2019) (14)
[Cimetidine therapy in radio-negative dyspepsia]. (1983) (14)
Additional antacid does not increase the effect of cimetidine in gastric ulcer disease. (1984) (14)
Health-related quality of life in inflammatory bowel disease in a Danish population-based inception cohort (2019) (13)
Impaired free water excretion in child C cirrhosis and ascites: relations to distal tubular function and the vasopressin system (2010) (13)
Adherence to guidelines in bleeding oesophageal varices and effects on outcome: comparison between a specialized unit and a community hospital (2010) (13)
Bacteriaemia after injection sclerotherapy of oesophageal varices. (2008) (13)
Hepatic-intestinal disposal of endogenous human alpha atrial natriuretic factor99-126 in patients with cirrhosis. (1990) (13)
NKG2D ligand expression in Crohn's disease and NKG2D-dependent stimulation of CD8+ T cell migration. (2017) (13)
Effect of N-acetylcysteine on the accuracy of the prothrombin time assay of plasma coagulation factor II+VII+X activity in subjects infused with the drug. Influence of time and temperature (2009) (12)
Effect of beta-adrenergic blockade on elevated arterial compliance and low systemic vascular resistance in cirrhosis. (2001) (12)
Few complications after paracentesis in patients with cirrhosis and refractory ascites. (2011) (12)
Increased Arterial Compliance in Cirrhosis is Related to Decreased Arterial C-type Natriuretic Peptide, but not to Atrial Natriuretic Peptide (2003) (11)
Systematic Review with Meta-analysis: The Impact of Co-occurring Immune-mediated Inflammatory Diseases on the Disease Course of Inflammatory Bowel Diseases. (2020) (11)
The soluble mannose receptor is released from the liver in cirrhotic patients, but is not associated with bacterial translocation (2017) (11)
Fibrogenesis and inflammation contribute to the pathogenesis of cirrhotic cardiomyopathy (2020) (11)
Transit-time analysis in hepatic cir rhosis (1999) (11)
Expression of vasoactive proteins in gastric antral mucosa reflects vascular dysfunction in patients with cirrhosis and portal hypertension (2015) (11)
Incidence, risk factors and evaluation of osteoporosis in patients with inflammatory bowel disease - a Danish population-based inception cohort with 10 years of follow-up. (2020) (10)
Atorvastatin for prevention of disease progression and hospitalisation in liver cirrhosis: protocol for a randomised, double-blind, placebo-controlled trial (2020) (9)
Total bile acid levels are associated with left atrial volume and cardiac output in patients with cirrhosis (2017) (9)
Hyponatremia in patients treated with terlipressin: Mechanisms and implications for clinical practice (2011) (9)
Prevalence and Risk Factors of Moderate to Severe Hepatic Steatosis in HIV Infection: The Copenhagen Co-Morbidity Liver Study. (2020) (9)
Gastric potential difference and pH in ulcer patients and normal volunteers during Stroop's colour word conflict test. (1989) (9)
Systematic review of the prevalence and development of osteoporosis or low bone mineral density and its risk factors in patients with inflammatory bowel disease (2020) (9)
Reduced baroreflex sensitivity and pulmonary dysfunction in alcoholic cirrhosis: effect of hyperoxia. (2010) (9)
Comparative pharmacokinetics and pharmacodynamics of lisinopril and enalapril, alone and in combination with propranolol. (1989) (9)
Detection of early central circulatory transits in patients with cirrhosis by gamma variate fit of indicator dilution profiles. (2005) (9)
Vedolizumab as the first line of biologic therapy for ulcerative colitis and Crohn's disease – a systematic review with meta-analysis (2021) (8)
Immunologic, hemodynamic, and adrenal incompetence in cirrhosis: impact on renal dysfunction (2014) (8)
Pronounced Coronary Arteriosclerosis in Cirrhosis: Influence on Cardiac Function and Survival? (2018) (8)
Acetaminophen toxicity induces mitochondrial complex I inhibition in human liver tissue (2020) (8)
Prognosis in patients with cirrhosis and mild portal hypertension (2006) (8)
Treatment of ascites and spontaneous bacterial peritonitis - part I. (2012) (8)
Splanchnic removal of human alpha-atrial natriuretic peptide in humans: enhancement after food intake. (1990) (8)
Long-term Compliance with Oral 5-aminosalicylic Acid Therapy and Risk of Disease Recurrence in Patients with Ulcerative Colitis: A Population-based Cohort Study (2016) (8)
Total plasma clearance versus urinary plasma clearance of 51Cr-EDTA in patients with cirrhosis with and without fluid retention (2015) (7)
Arterial pressure profile in patients with cirrhosis: Fourier analysis of arterial pulse in relation to pressure level, stroke volume, and severity of disease: On the reduction of afterload in the hyperdynamic syndrome (2012) (7)
Predictive value of indocyanine green retention test and indocyanine green clearance in Child‐Pugh class A patients (2015) (7)
Circulating nitric oxide products do not solely reflect nitric oxide release in cirrhosis and portal hypertension (2011) (7)
Normal red cell cardiac output in the hyperkinetic syndrome of alcoholic cirrhosis. (2001) (7)
Intraduodenal pH During Omeprazole Treatment in Duodenal Ulcer Patients (1986) (7)
755 CARDIAC FUNCTION STUDIED BY DOBUTAMIN STRESS MRI IN PATIENTS WITH MILD CIRRHOSIS (2009) (7)
Increased prevalence of liver fibrosis in people living with HIV without viral hepatitis compared to population controls. (2020) (6)
High Abundance of Proteobacteria in Ileo-Anal Pouch Anastomosis and Increased Abundance of Fusobacteria Associated with Increased Pouch Inflammation (2020) (6)
No effect of rifaximin on soluble CD163, mannose receptor or type III and IV neoepitope collagen markers in decompensated cirrhosis: Results from a randomized, placebo controlled trial (2018) (6)
Effects of Transjugular Intrahepatic Portosystemic Shunt (Tips) on Blood Volume Distribution in Patients with Cirrhosis (2016) (6)
99mTc‐labelled human serum albumin cannot replace 125I‐labelled human serum albumin to determine plasma volume in patients with liver disease (2013) (6)
Effects of a single dose of terlipressin on transcutaneous oxygen pressures (2010) (6)
Assessment of central blook volume in cirrhosis by radionusclide angiography: What does it really mean? (1994) (6)
[234] CARDIAC EFFECTS OF TERLIPRESSIN IN CIRRHOSI S. UNMASKING A CIRRHOTIC CARDIOMYOPATHY? (2007) (6)
Left atrial volume changes assessed by real time 3-dimensional echocardiography in relation to liver function and prognosis in patients with cirrhosis (2020) (6)
Plasma ADAMTS-13 protein is not associated with portal hypertension or hemodynamic changes in patients with cirrhosis. (2016) (6)
Vedolizumab as first-line biological therapy in elderly patients and those with contraindications for anti-TNF therapy: a real-world, nationwide cohort of patients with inflammatory bowel diseases (2021) (6)
S1363 Risk Factors for Progression From Acute to Chronic Pancreatitis (2010) (6)
Plasma volume changes during hypoglycaemia: the effect of arterial blood sampling. (1990) (6)
Long-Term, Clinical Follow-Up in Fatty Liver Patients (2011) (6)
Terlipressin vs. Octreotide in Bleeding Esophageal Varices (2009) (6)
Hepatic steatosis associated with exposure to elvitegravir and raltegravir. (2021) (6)
Disposal of atrial natriuretic factor (ANF99-126) in patients with cirrhosis: effect of beta-adrenergic blockade. (1993) (5)
The royal free hospital cirrhosis glomerular filtration rate: Validation in a danish cohort (2017) (5)
Rifaximin for people with hepatic encephalopathy (2015) (5)
Neutrophil gelatinase‐associated lipocalin and cystatin C in cirrhosis and portal hypertension: Relations to organ extraction and dysfunction (2017) (5)
Hepatic and cardiac hemodynamics and systemic inflammation in cirrhosis: It takes three to tango. (2018) (5)
Using MR elastography to assess portal hypertension and response to beta‐blockers in patients with cirrhosis (2021) (5)
Endoscopic ultrasound duplex scanning for measurement of portal venous flow. Validation against transit time ultrasound flowmetry in pigs. (1999) (5)
Effects of the vasopressin agonist terlipressin on plasma cAMP and ENaC excretion in the urine in patients with cirrhosis and water retention (2011) (5)
Effect of omeprazole on intragastric and duodenal bulb acidity in duodenal ulcer patients (1989) (5)
Inflammatory Bowel Diseases Affect the Phenotype and Disease Course of Coexisting Immune-Mediated Inflammatory Diseases: A Systematic Review With Meta-Analysis. (2022) (5)
Dobutamine reverses the cardio-suppressive effects of terlipressin without improving renal function in cirrhosis and ascites: a randomised controlled trial. (2019) (5)
Volume expansion in patients with cirrhosis (2002) (5)
Low ascitic fluid total protein levels is not associated to the development of spontaneous bacterial peritonitis in a cohort of 274 patients with cirrhosis (2018) (5)
Effects on plasma angiotensin-converting enzyme activity and circulating renin of lisinopril and enalapril alone and in combination with propranolol in healthy volunteers. (1999) (4)
[Cirrhotic cardiomyopathy: prolonged QTc-interval and dyssynchronic electrical and mechanical systole in cirrhosis]. (2004) (4)
Ehealth: Impact of Web-Based Treatment Optimization Solution (Traffic Light) on the Quality of Life in Crohn's Disease Patients Treated With Infliximab (2011) (4)
The impact of rifaximin on inflammation and metabolism in alcoholic hepatitis: A randomized clinical trial (2022) (4)
Pathophysiological-based treatments of complications of cirrhosis (2020) (4)
Cardiac Biomarkers in Cirrhosis and Portal Hypertension: Relation to Circulatory and Cardiac Dysfunction (2015) (4)
Effect of meal and propranolol on whole body and splanchnic oxygen consumption in patients with cirrhosis. (2006) (4)
Cardiovascular Mapping in Cirrhosis From the Compensated Stage to Hepatorenal Syndrome: A Magnetic Resonance Study (2022) (4)
Influence of NAFLD and bariatric surgery on hepatic and adipose tissue mitochondrial biogenesis and respiration (2022) (4)
Acyclovir in the prevention of duodenal ulcer recurrence. (1990) (4)
Assessment of portal hypertension severity using machine learning models in patients with compensated cirrhosis. (2022) (3)
Assessment of central blood volume in cirrhosis by radionuclide angiography (1994) (3)
295 LOW CARDIAC INDEX PREDICTS SURVIVAL AND RENAL FAILURE IN PATIENTS WITH ASCITES. EVIDENCE OF A HEART-KIDNEY AXIS IN CIRRHOSIS (2008) (3)
Systematic review and meta-analysis: the impact of co-occurring immune-mediated inflammatory diseases on the disease localization and behavior of Crohn’s disease (2021) (3)
Single-cell transcriptome and cell type-specific molecular pathways of human non-alcoholic steatohepatitis (2022) (3)
The Psychometric Hepatic Encephalopathy Syndrome score does not correlate with blood ammonia, endotoxins or markers of inflammation in patients with cirrhosis. (2021) (3)
Short and long-term effectiveness and safety of vedolizumab in treatment-refractory patients with ulcerative colitis and Crohn’s disease – a real-world two-center cohort study (2021) (3)
Advances in the treatment of portal hypertension in cirrhosis (2016) (3)
Effects of octreotide on serum insulin-like growth factor I and insulin-like growth factor binding proteins in patients with cirrhosis (2002) (3)
NAFLD: Cardiovascular complications of NAFLD—they do matter (2015) (3)
[Effect of N-acetylcysteine on prothrombin index in patients with uncomplicated paracetamol poisoning]. (2004) (3)
Low incidence of non-alcoholic steatohepatitis in a Danish liver unit. (2012) (3)
Poor concordance between liver stiffness and non-invasive fibrosis scores in HIV infection without viral hepatitis. (2020) (3)
[The histological picture of the gastric and duodenal mucosa in X-ray negative dyspepsia. Before and after treatment with cimetidine]. (1984) (3)
[Cirrhosis of the liver]. (2014) (3)
Duodenal ulcer healing on 2 g of sucralfate daily at bedtime compared to 1 g four times daily (1990) (3)
Fourier analysis of arterial pulse in patients with advanced cirrhosis indicates reduced wave reflections that may protect against manifest cardiac dysfunction (2011) (3)
Are specific guidelines necessary for treatment of esophageal varices in the Nordic countries? (2009) (3)
Bleeding oesophageal varices. (1996) (3)
[Liver biopsy in liver patients with coagulopathy]. (2008) (3)
Carvedilol versus non‐selective beta‐blockers for portal hypertension in cirrhosis (2015) (3)
Presence of alcoholic steatohepatitis, but no selective histological feature, indicates an increased risk of cirrhosis and premature death (2016) (3)
Predictors of response and disease course in patients with inflammatory bowel disease treated with biological therapy—the Danish IBD Biobank Project: protocol for a multicentre prospective cohort study (2020) (3)
There is room for diminished central and arterial blood volume in cirrhosis (1991) (3)
Aquaporin‐2 excretion in hospitalized patients with cirrhosis: Relation to development of renal insufficiency and mortality (2017) (3)
Effects of treatment with &bgr;-blocker and aldosterone antagonist on central and peripheral haemodynamics and oxygenation in cirrhosis (2011) (3)
Gamma‐variate plasma clearance versus urinary plasma clearance of 51Cr‐EDTA in patients with cirrhosis with and without fluid retention (2017) (2)
Central blood volume in cirrhosis (1993) (2)
[Hepatorenal syndrome: diagnosis, treatment and prevention]. (2013) (2)
[Cocaine-triggered ischaemic enteritis]. (2009) (2)
Integrative genomic profiling of hepatocellular adeno- mas identify mutational processes involved in malignant transformation (2013) (2)
P813 Occurrence, disease course and prognosis of perianal Crohn’s disease in a Danish population-based inception cohort—a 10-year follow-up study (2018) (2)
Variceal Rebleeding: Drugs, Endoscopy or Both (2014) (2)
[Esophago-gastro-duodenoscopy of pediatric patients]. (1997) (2)
A Danish population-based case series of patients with liver cirrhosis and coronavirus disease 2019 (2021) (2)
[Prediction of bleeding risks and death in cirrhosis based on hemodynamic and metabolic variables. A study of patients with esophageal varices without previous bleeding]. (1995) (2)
[Increased survival following antibiotic prophylaxis in patients with cirrhosis and upper gastrointestinal hemorrhage]. (2005) (2)
Pharmacological effects are model specific in animal models of portal hypertension (2008) (2)
Oesophageal varices prior to bleeding. Diagnosis and physiological and therapeutic effects of propranolol in cirrhosis. (1993) (2)
DOP041 Surgery and hospitalisation in patients with inflammatory bowel disease; 10-year follow-up of a Danish population-based inception cohort (2018) (1)
Editorial: the role of statins in the treatment of alcohol‐related cirrhosis – Authors’ reply (2017) (1)
Effect on splanchnic and systemic haemodynamics of a liquid meal alone and in combination with propranolol in patients with cirrhosis (1991) (1)
P1337 : Randomized trial with rifaximin in liver cirrhosis. Effects on the haemodynamic and inflammatory state (2015) (1)
Transjugular intrahepatic portosystemic shunt: impact on systemic haemodynamics and renal and cardiac function in patients with cirrhosis (2017) (1)
The use of proton pump inhibitors among patients with alcoholic cirrhosis is not related with increased risk of death (2018) (1)
P613 Surgery rates in Danish incident cases of ulcerative colitis and Crohn's disease in the era of biological treatment – a seven-year cohort study follow up (2013) (1)
Association of low mechano‐energetic efficiency and prognosis in liver cirrhosis (2022) (1)
Reply: To PMID 24389306. (2014) (1)
527 IMBALANCES IN PROINFLAMMATORY CYTOKINES ARE ASSOCIATED WITH PULMONARY DYSFUNCTION AND HEPATOPULMONARY SYNDROME IN CIRRHOSIS (2010) (1)
Outcomes of COVID-19 among Patients with Chronic Liver Disease: A Danish Prospective, Population-Based Cohort Study (2022) (1)
In Crohn’s Disease, an Aggressive Disease Course is Related to an Increased Abundancy of Proteobacteria; A Seven Year Follow Up Study (2017) (1)
[Patients with decompensated cirrhosis should be offered rehabilitation at discharge]. (2013) (1)
Letter: safety and efficacy of using statins in patients with cirrhosis—authors' reply (2017) (1)
Pathophysiology Behind Cardiopulmonary Complications of Cirrhosis and Portal Hypertension (2020) (1)
Deep Learning Surpasses Gastrointestinal Experts at Classifying Endoscopic Severity in Patients with Ulcerative Colitis (2021) (1)
Electro-mechanical dissociation in the heart in patients with cirrhosis (2001) (1)
Postprandial Increase in Mesenteric Blood Flow is Attenuated in Parkinson’s Disease: A Dynamic PC-MRI Study (2021) (1)
[Treatment of esophageal varices]. (2001) (1)
Gastric Emptying Is Not Delayed and Does Not Correlate With Attenuated Postprandial Blood Flow Increase in Medicated Patients With Early Parkinson's Disease (2022) (1)
Treatment of the hepatorenal syndrome and hyponatremia in cirrhosis - part II. (2012) (1)
DOP82 Direct and indirect costs of inflammatory bowel disease in the biological era; 10 years of follow-up in a Danish population-based inception cohort (2019) (1)
Cardiac fibrosis and coronary atherosclerosis in cirrhosis. Indications of cirrhotic cardiomyopathy (2018) (1)
205 RELATION BETWEEN BAROREFLEX SENSITIVITY AND PULMONARY DYSFUNCTION IN CIRRHOSIS: EFFECT OF HYPEROXIA (2009) (1)
The role of bile acids in the development of structural myocardial changes and cardiac dysfunction in patients with cirrhosis (2018) (1)
Azygos and hepatic extraction of atrial natriuretic factor (ANF) in patients with cirrhosis. No evidence of reduced disposal. (1993) (1)
Enhanced processing of von Willebrand factor reflects disease severity and discriminates severe portal hypertension in cirrhosis (2019) (1)
Determination of hepatic clearance by derivations of the indocyanine green retention test in cirrhosis (2022) (1)
169 CARVEDILOL OR PROPRANOLOL IN PORTAL HYPERTENSION? A RANDOMIZED CLINICAL TRIAL (2010) (1)
[Treatment of bleeding from oesophageal varices in patients with cirrhosis]. (2007) (1)
[The hepatorenal syndrome. From physiopathology to clinical practice]. (2004) (1)
High Accuracy in Classifying Endoscopic Severity in Ulcerative Colitis Using Convolutional Neural Network (2022) (1)
The PHES Score Does Not Correlate With Blood Ammonia Levels, Circulating Endotoxins or Markers of Systemic Inflammation (2017) (0)
[Intestinal lympho-nodular hyperplasia associated with hypogammaglobulinemia]. (1981) (0)
Su1080 Increased Risk of Work Disability in Inflammatory Bowel Disease Patients After Seven Years of Follow-Up - A Population-Based Cohort Study (2015) (0)
Long-time effects of a slow release somatostatin analogue (Lanreotide SR) on hepatic venous pressure gradient in patients with proven esophageal varices (2003) (0)
P347 Vedolizumab as first line biologic therapy in elderly patients with contraindications against anti-TNF therapy - A real-world nationwide cohort of patients with inflammatory bowel diseases (2021) (0)
Pancreatic insufficiency (2020) (0)
Collagen type IV remodeling gender-specifically predicts mortality in decompensated liver cirrhosis (2019) (0)
Blunted cardiovascular effects of beta-blockers in patients with cirrhosis: Relation to severity? (2022) (0)
733 NEOEPITOPES DERIVED FROM EXTRACELLULAR MATRIX DEGRADATION REFLECT LIVER FUNCTION, FIBROSIS AND HVPG IN HIV-PATIENTS (2013) (0)
Systemic inflammation is associated with cardiodynamic state in acute-on-chronic liver failure (2020) (0)
DOP43 Impact of Inflammatory Bowel Diseases on the phenotype and severity of psoriasis and spondyloarthropathies (2021) (0)
Nurse assisted follow-up after admission with decompensation in cirrhosis: a systematic review and meta-analysis (2020) (0)
294 CRITICAL ISCHAEMIA IN PERIPHERAL LIMBS DURING TERLIPRESSIN TREATMENT (2008) (0)
SAT-027-Effects of propranolol on liver- and spleen-stiffness measured by MR-Elastography in patients with cirrhosis (2019) (0)
FRI-130-Changes in the extracellular matrix of the heart and the liver assessed by MRI with T1-mapping are closely linked in cirrhosis: Is inflammation the shared pathway? (2019) (0)
M1383 Mortality and Prognostic Factors in Chronic Pancreatitis - A Long-Term Follow-up Study of a Danish Cohort (2010) (0)
Session 8: Providing Scientific Evidence: RCTs and Beyond (2007) (0)
Different inflammasome activation predisposes for acute-on-chronic liver failure depending on hepatic compensation in human and experimental liver cirrhosis (2020) (0)
[Violence against women in their partnerships. III. Education, employment and housing]. (1985) (0)
Tu1171 Reduced Recurrence Rates in Crohn's Disease but Not in Ulcerative Colitis in the Era of Immunomodulators and Biological Therapy: A 7-Year Population-Based Follow-Up Study of Inflammatory Bowel Disease (2014) (0)
Subject Index Vol. 28, 2010 (2011) (0)
OP07 Artificial intelligence surpasses gastrointestinal experts in the classification of endoscopic severity among Ulcerative Colitis (2021) (0)
585 CARDIAC ADRENERGIC FUNCTION ASSESSED BY I-METAIODOBENZYL/GUANIDINE MYOCARDIAL SCINTIGRAPHY IN PATIENTS WITH CIRRHOSIS (2012) (0)
Reply to de Vries HE, Van Oijen MGH, de Jong DJ. Safety of infliximab in inflammatory bowel disease needs to be debated. Clin Gastroenterol Hepatol 2009;7:603-604. (2009) (0)
Contents Vol. 28, 2010 (2011) (0)
[Acute pulmonary failure in acetylsalicylic acid poisoning]. (1987) (0)
The Use and Efficacy of Biological Therapies for Inflammatory Bowel Disease in a Danish Tertiary Centre 2010–2020 (2022) (0)
[Ranitidine versus cimetidine in duodenal ulcer. Pharmcokinetic and pharmacodynamic studies]. (1983) (0)
[Old wine in new bottles: Lactulose works in hepatic encephalopathy]. (2016) (0)
Cardiovascular Effects of a Transjugular Intrahepatic Portosystemic Shunt in Patients with Cirrhosis (2017) (0)
P703 Risk of disease progression in patients with Crohn's disease after 7 years of follow-up in a Danish population-based inception cohort. (2017) (0)
[Violence to women in their partnerships. I. Occurrence, mechanisms of injury, types of injury and treatment]. (1985) (0)
[Terlipressin acetate]. (2022) (0)
Central blood volume in cirrhosis: Relationship to sympathetic nervous activity and atrial natriuretic factor (ANF) (1991) (0)
Distribution of blood volumes in cirrhosis. Relation to gender and antropometrics (2003) (0)
Sa1047 Increased Hepatic Iron Deposition and Long-Term Prognosis of Patients With Nonalcoholic Fatty Liver Disease (2014) (0)
P743 Bone mineral disease is insufficiently evaluated in patients with inflammatory bowel disease at risk of metabolic bone disease: results from a Danish population-based inception cohort study (2019) (0)
P939 NGAL IN PATIENTS WITH LIVER CIRRHOSIS: RELATION TO PATIENT CHARACTERISTICS AND KINETICS (2014) (0)
P634 Predictors of response and course in patients with inflammatory bowel disease treated with biological therapy: The Danish IBD-Biobank project (2020) (0)
SAT-055-Dobutamine counteracts the decrease in cardiac output after terlipressin in patients with cirrhosis and impaired kidney function but does not improve GFR: A randomised exploratory trial (2019) (0)
MRI-derived myocardial extracellular volume is closely associated with markers of collagen formation in cirrhosis (2020) (0)
Acknowledgement to our reviewers (2006) (0)
P597 Reduced recurrence rates in Crohn's disease in the era of biological therapy: A 7-year population-based follow-up study of inflammatory bowel disease (2014) (0)
P127 Environmental Factors in an Inception Cohort of IBD Patients With a Steep Increase of Incidence From 2003–2005 in Copenhagen County and City: A DCCD Study (2007) (0)
[Alcohol-related liver cirrhosis and related complications]. (2021) (0)
Effect of beta-adrenergic blockade on elevated arterial and low systemic vascular resistance compliance in cirrhosis (2001) (0)
[Ranitidine (Zantac). A new H2 receptor antagonist]. (1983) (0)
Gluco-regulatory disturbances in primary biliary cholangitis and non-alcoholic fatty liver disease compared with healthy individuals (2022) (0)
Systemic inflammation is associated with hyperdynamic circulation and predicts acute-on-chronic liver failure (2020) (0)
[Portal pressure should be measured on suspicion of portal hypertension]. (2010) (0)
Evidence of a vasopressin-independent AQP2 expression and water retention in patients with Child C cirrhosis and ascites (2008) (0)
P786 The use and escalation of treatments in patients with inflammatory bowel disease; a 10 years follow-up of a Danish population-based inception cohort (2018) (0)
Statins for cirrhosis: almost ready for clinical application (2020) (0)
Machine learning models for prediction of severe portal hypertension in patients with compensated cirrhosis (2022) (0)
A Note of Thanks to Referees (1997) (0)
[Violence to women in their partnerships. II. Demographic conditions (age, marital status and children)]. (1985) (0)
The risk of fractures in cirrhosis and chronic pancreatitis. a danish nationwide retrospective matched cohort study (2013) (0)
Propranolol reduces the meal-induced increase in oxygen consumption in patients with cirrhosis (2002) (0)
176 EFFECTS OF TREATMENT WITH BETA-BLOCKER AND ALDOSTERONE ANTAGONIST ON CENTRAL AND PERIPHERAL HAEMODYNAMICS AND OXYGENATION IN CIRRHOSIS (2011) (0)
function portal hypertension : relation to autonomic and cardiac IBG in cirrhosis and m Cardiac sympathetic imaging with (2014) (0)
[Magnetic resonance imaging for the diagnosis of non-alcoholic fatty liver disease]. (2019) (0)
710 TIMP-1 IN PATIENTS WITH CIRRHOSIS: RELATION TO LIVER DYSFUNCTION, PORTAL HYPERTENSION, AND HAEMODYNAMIC CHANGES (2013) (0)
P940 IS CYSTATIN C (CYSTC) AN IDEAL MARKER OF RENAL DYSFUNCTION IN CIRRHOSIS (2014) (0)
584 NEW VASCULAR BIOMARKERS IN CIRRHOSIS: ORGAN EXTRACTION AND RELATION TO THE VASODILATORY STATE (2013) (0)
Terlipressin vs. Octreotide in Bleeding Esophageal Varices. Authors' reply (2009) (0)
Increased levels of soluble mannose receptor are associated with poor outcome in cirrhosis: results from a 2-year longitudinal study (2020) (0)
247 HIGH LEVELS OF SOLUBLE TNF-ALPHA-RECEPTOR-I ARE ASSOCIATED WITH POOR OUTCOME IN CIRRHOSIS WITH PORTAL HYPERTENSION (2013) (0)
The Intestinal Dysbiosis Found in IBD-Patients are Linked to Colonization with Extra-Intestinal Pathogenic Escherichia Coli (2017) (0)
Normal red blood cell cardiac output in hyperkinetic syndrome of alcoholic cirrhosis (2001) (0)
The composition of the bile acid pool is closely associated with fibrosis in the heart and liver of patients with cirrhosis (2022) (0)
Nurse-assisted and multidisciplinary outpatient follow-up among patients with decompensated liver cirrhosis: A systematic review (2023) (0)
636 EFFECTS OF ALPHA- AND BETA-ADRENERGIC BLOCKADE ON CIRCULATORY REGULATION AND OXYGENATION IN CIRRHOSIS (2012) (0)
Demographic , clinical , and biochemical characteristics of 22 patients with cirrhosis and ascites (2008) (0)
193 DETERMINANTS OF THE HYPERDYNAMIC CIRCULATION AND CENTRAL HYPOVOLAEMIA IN CIRRHOSIS AND PORTAL HYPERTENSION (2009) (0)
591 BACTERIAL DNA MEASUREMENTS IN PATIENTS WITH CIRRHOSIS UNDERGOING TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT (TIPS) INSERTION (2013) (0)
S1961 Critical Ischaemia in Peripheral Limbs During Terlipressin Treatment (2008) (0)
Altered serum bile acid composition is associated with cardiac dysfunction in cirrhosis. (2023) (0)
[Treatment of varices]. (1996) (0)
[Choice of antibiotics in diarrhea due to Clostridium difficile]. (1999) (0)
Nurse-driven post-discharge intervention reduces risk of readmission and non-attendance in patients with decompensated liver cirrhosis: a randomized controlled study (2022) (0)
[Portal hypertension]. (1996) (0)
Red blood cell sodium transport in patients with cirrhosis (2016) (0)
[Cirrhotic cardiomyopathy: increased circulating pro-brain natriuretic peptide and brain natriuretic peptide in cirrhosis]. (2004) (0)
Octreotide in cirrhotic patients (1998) (0)
Adult Non-alcoholic Fatty Liver Disease (NAFLD) (2018) (0)
Influence of Genetics, Immunity and the Microbiome on the Prognosis of Inflammatory Bowel Disease (IBD Prognosis Study): the protocol for a Copenhagen IBD Inception Cohort Study (2022) (0)
[Violence against women in their partnerships. IV. Pattern of contact with public institutions]. (1985) (0)
P1102 : No histological features of alcohol induced steatohepatitis can identify patients at risk of cirrhosis and premature death (2015) (0)
The effect of terlipressin on blood volume distribution in patients with cirrhosis (2002) (0)
Hemodynamic and humoral effects of posture in patients with cirrhosis and in controls (2003) (0)
P516 Pro-C5: A NOVEL SEROLOGICAL MARKER OF TRUE TYPE V COLLAGEN FORMATION DETECTS PORTAL HYPERTENSION IN CIRRHOSIS (2014) (0)
Patients with alcoholic-related cirrhosis have high burden of coronary arteriosclerosis compared to non-alcohol-related cirrhosis (2017) (0)
Pitfalls in the assessment of intrapulmonary shunt using lung perfusion scintigraphy in patients with cirrhosis: authors' reply (2011) (0)
Letter to the editorReply from the authors (1989) (0)
DOP003 Proximal disease extension in patients with limited ulcerative colitis: a Danish population-based inception cohort. (2017) (0)
188 Reduced baroreceptor reflex sensitivity in cirrhosis. Relations to central haemodynamics and humoral systems (2006) (0)
Failure to Control Bleeding and Failure to Control Rebleeding (2010) (0)
Plasma Cystatin C is a predictor of renal failure, hepatorenal syndrome, ACLF and mortality in patients with acutely decompensated liver cirrhosis (2016) (0)
OP19 Disease course and treatment outcomes of early resected Crohn’s Disease patients: A Danish nationwide cohort study from 1997 to 2015 (2021) (0)
801 - Liver Cirrhosis and Wound Healing: Activation of Von Willebrand Factor and Platelets (2018) (0)
Liver cirrhosis and wound healing: Activation of von Willebrand factor and platelets (2018) (0)
584 ASSOCIATIONS BETWEEN BAROREFLEX SENSITIVITY, CARDIOVASCULAR REGULATION AND CENTRAL HYPOVOLAEMIA IN CIRRHOSIS AND PORTAL HYPERTENSION (2012) (0)
Renal and circulatory effects of terlipressin in patients with hepatorenal syndrome assessed by magnetic resonance imaging (2022) (0)
751 THE ARTERIAL PRESSURE PROFILE IN PATIENTS WITH CIRRHOSIS. FOURIER ANALYSIS IN RELATION TO PRESSURE LEVEL, STROKE VOLUME, AND SEVERITY OF DISEASE (2009) (0)
[Surgical treatment of diabetes mellitus type 2]. (2009) (0)
P261 Systematic review with meta-analysis: The impact of concomitant immune-mediated diseases on the disease course of inflammatory bowel disease (2020) (0)
P769 In Crohn's disease, an aggressive disease course is related to an increased abundancy of proteobacteria: a seven year follow up study. (2017) (0)
SAT-138-Cirrhotic cardiomyopathy: A 2-year longitudinal follow-up study using advanced cardiac imaging (2019) (0)
582 Histology and prognosis in fatty liver patients (2004) (0)
Hepatorenalt syndrom: diagnose, behandling og forebyggelse: diagnosis, treatment and prevention (2013) (0)
[Adverse effects should be reported]. (2001) (0)
S1962 Effects of Terlipressin On the Aquaretic System - Evidence of Antidiuretic Effects (2008) (0)
[Cochrane review about the effect of acamprosate]. (2010) (0)
252 EFFECTS OF TERLIPRESSIN ON THE AQUARETIC SYSTEM. EVIDENCE OF ANTIDIURETIC EFFECTS (2008) (0)
610 PROGNOSTIC POTENTIAL OF CARDIAC AND PROINFLAMMATORY MARKERS IN CIRRHOSIS (2013) (0)
[Etiology of acute and chronic pancreatitis over time at a hospital in Copenhagen]. (2010) (0)
[Prognosis in hepatic steatosis]. (1997) (0)
TREATMENT OF HEPATIC ENCEPHALOPATHY : TARGETING THE GUT-LIVER-BRAIN AXIS Summary of Presentations from the Norgine Sponsored Satellite Symposium , UEG Week , Berlin , Germany , 12 th – 16 th October 2013 (2013) (0)
Disease Activity Patterns of Inflammatory Bowel Disease - A Danish Nationwide Cohort Study 1995-2018. (2022) (0)
An unusual case of chylous ascites: A case report (2014) (0)
177 SPLANCHNIC DETERMINANTS OF THE HYPERDYNAMIC CIRCULATION AND CENTRAL HYPOVOLAEMIA IN CIRRHOSIS (2010) (0)
Arterial compliance in cirrhosis. Relation to pathophysiology andeffect of vasoconstriction (2000) (0)
Effects of chronic octreotide treatment on renal function in cirrhotic patients: a randomised, double-blind, controlled trial (2001) (0)
225 THE PROTEIN FINGERPRINT TECHNOLOGY REFLECTS LIVER FUNCTION AND DETECTS CLINICALLY SIGNIFICANT PORTAL HYPERTENSION IN PATIENTS WITH ALCOHOLIC LIVER CIRRHOSIS (2013) (0)
P421 Treatment optimization with vedolizumab in treatment-refractory patients with ulcerative colitis and Crohn’s disease – a real-world two-center cohort study (2021) (0)
572 CARDIAC FUNCTION AND DYNAMICS OF QT INTERVAL IN PATIENTS WITH MILD CIRRHOSIS DURING MAXIMAL BETA-ADRENERGIC DRIVE: A DOBUTAMIN STRESS STUDY (2012) (0)
pegylated interferon plus ribavirin in patients with chronic hepatitis C: A prospective randomized pilot study (2012) (0)
Effect of paracetamol poisoning on international normalised ratio (2003) (0)
Aquaporin-2 in Cirrhosis: Relation to Disease Severity, Markers of Renal Function and Impact on Development of Renal Insufficiency and Mortality (2016) (0)
Biomarkers reflecting pericellular fibrosis improve together with liver histology after bariatric surgery in early non-alcoholic fatty liver disease. (2022) (0)
90 EVIDENCE OF A VASOPRESSIN-INDEPENDENT AQP2 EXPRESSION AND WATER RETENTION IN REFRACTORY ASCITES (2008) (0)
206 RIFAXIMIN IN THE TREATMENT AND PROPHYLAXIS OF HEPATIC ENCEPHALOPATHY IN CHRONIC LIVER DISEASE: A META-ANALYSIS (2013) (0)
[The diuretic profiles of Lasix and Ladix Retard. A comparative clinical study]. (1982) (0)
Haemodynamic and humoral effects of posture in patients with cirrhosis and controls (2003) (0)
[238] PULMONARY FUNCTION IN CIRRHOSIS: LOW PREVALENCE OF THE HEPATOPULMONARY SYNDROME (2007) (0)

This paper list is powered by the following services:

What Schools Are Affiliated With Flemming Bendtsen?

Flemming Bendtsen is affiliated with the following schools:

University of Copenhagen